Posts by: Marta Figueiredo PhD

Marta Figueiredo PhD

Marta Figueiredo holds a master’s in evolutionary and developmental biology and a PhD in biomedical sciences from the University of Lisbon, Portugal. Her research is focused on the role of several signaling pathways in thymus and parathyroid glands embryonic development.

March 4, 2021March 4, 2021

P. aeruginosa Resistance May Be Measure of Ability to Hijack CF Mucus

cystic fibrosis

Pel, a complex sugar molecule produced by Pseudomonas aeruginosa, contributes to the bacterium’s ability to aggregate and resist both antibiotics and mucus thinners in people with cystic fibrosis (CF) by binding to an ... Read more

March 1, 2021March 1, 2021

USACFA Accepting Applications for Scholarships in Arts, Other Fields

News

The United States Adult CF Association (USACFA) is accepting applications to award a total of $15,000 in scholarships to four people with cystic fibrosis (CF)pursuing degrees in the creative arts ... Read more

February 22, 2021February 22, 2021

$1.4M Grant Supports Combo Approach to Antibiotic-resistant Infections

cystic fibrosis, News

Work targeting new therapies against antibiotic-resistant infections, led by West Virginia University (WVU) researchers, received a $1.4 million grant from a branch of the U.S. Department of Defense (DOD). The ... Read more

February 18, 2021February 18, 2021

Research Examines CF Patients’ Susceptibility to COVID-19

cystic fibrosis, News

Researchers have developed a patient-derived model of cystic fibrosis (CF) to better understand whether these patients are more susceptible to COVID-19 infection and its associated serious complications. The project is ... Read more

February 17, 2021February 17, 2021

Eurordis Survey: Healthcare Experience Worse for Rare Disease Patients

News, syndicated

People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of an international survey conducted by Eurordis-Rare Diseases Europe. Indeed, rare ... Read more

February 17, 2021February 18, 2021

ELX-02 Restores CFTR Activity in Organoids With G542X Mutations, Study Finds

News

ELX-02 restored the levels and function of CFTR — the defective protein in CF — in “mini-organs,” or organoids, derived from patients carrying the most common CF-causing nonsense mutation, a ... Read more

January 26, 2021January 26, 2021

Pneumonia Seen as More Likely in CF Patients, Carriers of European Ancestry

cystic fibrosis, News

Cystic fibrosis (CF) patients and carriers — those with mutations in only one copy of the CFTR, the gene associated with CF — of European ancestry are at a higher risk ... Read more

January 21, 2021January 21, 2021

COVID-19 Lockdown Linked to Fewer Flares in Children in Small Study

cystic fibrosis, News

Limits placed on social interaction by the COVID‐19 pandemic appear to have led to a drop in the number of pulmonary exacerbations — periods of a sudden worsening in lung health — ... Read more

December 22, 2020January 5, 2021

FDA Expands Labels for 3 Vertex CFTR Modulators

cystic fibrosis, News

The U.S. Food and Drug Administration (FDA) has expanded the number of cystic fibrosis (CF)-related mutations considered responsive to and therefore eligible for Vertex Pharmaceuticals‘ three approved therapies. With these approvals, ... Read more

December 15, 2020December 15, 2020

CF Foundation Awards Research Projects to Advance Therapies for All CF Patients

cystic fibrosis, News

The Cystic Fibrosis Foundation has awarded a total of $1.7 million in nine grants to research projects focused on tools and strategies to advance therapies for all cystic fibrosis (CF) ... Read more

Join our email list!